DNA methyltransferase I (DNMT1) and another histone methyltransferase, PcG protein enhancer of zeste homolog 2 (EZH2) bind with miR200a/b/429 promoter region and inhibit miR200a/b/429 expression in HCC and glioma cells. Here, DNMT1 is linked to hepatocellular carcinoma.